Clinical trials
Squamous Cell Carcinoma of Head and Neck trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Unknown status | 7 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Cancer Hospital and Research Institute | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Sun Yat-sen University | 2 |
| American College of Radiology Imaging Network | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 1 |
| Grit Biotechnology | 1 |
| Hainan Medical College | 1 |
| Huashan Hospital | 1 |
| Jinsong Hou | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 20 |
| Mouth Neoplasms | 2 |
| Carcinoma, Squamous Cell | 1 |
| Head and Neck Neoplasms | 1 |
| Lymphatic Metastasis | 1 |
| Lymphedema | 1 |
| Margins of Excision | 1 |
| Nasopharyngeal Carcinoma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplastic Cells, Circulating | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.